SLK Polyclonal Antibody

Rabbit Anti-SLK Polyclonal Antibody

Product Specifications

Background

SLK (STE20 Like Kinase) is a Protein Coding gene. Diseases associated with SLK include amyotrophic lateral sclerosis 9. Among its related pathways are Oocyte meiosis and Mitotic Roles of Polo Like Kinases. Gene Ontology (GO) annotations related to this gene include protein homodimerization activity and transferase activity, transferring phosphorus-containing groups. An important paralog of this gene is MAP4K3. Mediates apoptosis and actin stress fiber dissolution.

CAS Number

9007-83-4

Product Name Alternative

SLK; KIAA0204; STK2; STE20-like serine/threonine-protein kinase; STE20-like kinase; hSLK; CTCL tumor antigen se20-9; STE20-related serine/threonine-protein kinase; STE20-related kinase; Serine/threonine-protein kinase 2

Gene ID

9748

Accession Number

Q9H2G2

Reactivity

Human, Mouse, Rat

Immunogen

Synthesized peptide derived from the C-terminal region of human SLK at AA range: 1120-1200

Clonality

Polyclonal

Tag

STE20-like serine threonine-protein kinase

Applications

WB, IHC, IF, ELISA

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Molecular Weight

150kD

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

SLK Polyclonal Antibody detects endogenous levels of SLK protein.

Observed Molecular Weight

150

Formulation

Liquid solution

Buffer pH

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000; IHC 1:100-1:300; IF 1:200-1:1000; ELISA 1:5000; Not yet tested in other applications.